Nicardipine
Nicardipine is a calcium channel blocker used to treat hypertension and manage acute severe blood pressure elevations, including certain situations requiring intravenous treatment in hospital settings. It works by inhibiting calcium entry into vascular smooth muscle cells, causing arterial relaxation, reducing peripheral vascular resistance, and lowering blood pressure. Nicardipine is available in oral capsules and intravenous formulations, depending on the market and clinical indication. Common side effects include headache, flushing, dizziness, nausea, and swelling of the ankles or feet. It may also cause low blood pressure, rapid heart rate, and worsening of certain cardiac conditions, requiring caution in patients with heart failure or impaired liver function. Nicardipine should be used under medical supervision, with blood pressure and heart rate monitoring, particularly during intravenous administration.
Nicardipine was historically used as a respiratory medicine for the symptomatic management of certain respiratory conditions. Its former uses included:
is okay
The import of medicines into India is regulated by the Central Drugs Standard Control Organisation (CDSCO) under the Drugs and Cosmetics Act, 1940, and the Drugs and Cosmetics Rules, 1945. The regulatory requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished formulation, or an unapproved medicine intended for an individual patient's treatment.
Primeera Healthcare Private Limited can provide import coordination and pharmaceutical documentation assistance for Nicardipine, subject to confirmation of its current regulatory status and eligibility for import into India.
The export of Nicardipine from India is subject to applicable requirements under the Drugs and Cosmetics Act, 1940, the Drugs and Cosmetics Rules, 1945, and relevant export, customs, and destination-country regulations. Documentation requirements depend on whether the product is an active pharmaceutical ingredient (API), a finished pharmaceutical formulation, or a medicine intended for a specific market. Export eligibility and destination-country requirements must be verified before shipment.
Primeera Healthcare Private Limited can provide pharmaceutical export documentation assistance, regulatory coordination, and shipping support for Nicardipine, subject to confirmation of its export eligibility under applicable Indian regulations and the import requirements of the destination country.
If you have any questions or need any help, contact our Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
All Trademarks and Brands that appear on the website belong to their respective owners. Primeera Healthcare does not lay any claim on them; we only provide information.
